---
$id: https://graph.org.ai/products/commodity/51131627
$type: Product
source: UNSPSC
code: "51131627"
title: "Cangrelor"
class: "51131600"
classTitle: "Anticoagulants"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cangrelor

**UNSPSC Code**: 51131627
**Class**: [Anticoagulants](Anticoagulants.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiplatelet agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6AQ1Y404U7. European Medicines Agency schedules Cangrelor in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB26448. Cangrelor generally arises in the molecular formula C17H25CL2F3N5O12P3S2. The term CANGRELOR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, no. 3, 2000, list 44.) Most nations schedule cangrelor under HS 29349990 and SITC 51579. As of Q4 2014, CANGRELOR remains the US FDA Preferred Term for this commodity. Cangrelor bears US NLM identifiers UMLS ID C1121991 and NCI Concept Code C76395. SMILES: CLC(CL)(P(=O)(OP(=O)(OCC1OC(N2C3NC(SCCC(F)(F)F)NC(NCCSC)C3NC2)C(O)C1O)O)O)P(=O)(O)O.

